Capricor Therapeutics Overview
Capricor Therapeutics Target Price
See Capricor Therapeutics's analyst price targets ($14) vs the current share price.
Get informed when a big investor buys or sells
+ FollowShare Price
$8.29
Average Target Price
$13.88
67.4% upside
67.4% upside4 analysts in the last 4 months
High: $38 | Low: $3.5
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-07-29 | Cantor Fitzgerald | $3.5 |  57.8% downside |  |
| 2026-07-28 | Industrial Alliance Securities | $7 | 15.6% downside | |
| 2026-07-27 | Roth Capital | $7 | 15.6% downside | |
| 2026-05-15 | Roth CapitalBoobalan Pachaiyappan | $38 | 358.4% upside | |
| 2026-03-13 | Cantor FitzgeraldKristen Kluska | $62 | 647.9% upside | |
| 2025-12-15 | UBS | $50 | 503.1% upside | |
| 2025-12-10 | Piper Sandler | $45 | 442.8% upside | |
| 2025-12-08 | Oppenheimer | $54 | 551.4% upside | |
| 2025-12-04 | Maxim Group | $50 | 503.1% upside | |
| 2025-12-03 | Industrial Alliance Securities | $48 | 479% upside | |
| 2025-12-03 | H.C. Wainwright | $60 | 623.8% upside | |
| 2025-11-11 | Roth CapitalBoobalan Pachaiyappan | $13 | 56.8% upside | |
| 2025-07-11 | Piper SandlerEdward Tenthoff | $20 | 141.3% upside | |
| 2025-07-11 | H.C. WainwrightJoseph Pantginis | $24 | 189.5% upside | |
| 2024-10-21 | Piper SandlerEdward Tenthoff | $17.5 | 111.1% upside | |
| 2024-10-14 | OppenheimerLeland Gershall | $21.5 | 159.3% upside | |
| 2024-09-25 | Maxim GroupJason McCarthy | $12.5 | 50.8% upside | |
| 2024-09-25 | H.C. WainwrightJoseph Pantginis | $10 | 20.6% upside | |
| 2024-09-17 | OppenheimerLeland Gershall | $7.5 | 9.5% downside | |
| 2024-05-16 | OppenheimerLeland Gershall | $7 | 15.6% downside | |